Global Arteriotomy Closure Devices Market Size By Type (Passive Closure Devices, Active Closure Devices), By Application (Procedures by Femoral Arterial Access, Procedures by Transradial Arterial Acce...

The Global Arteriotomy Closure Devices Market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.3 billion by 2031, growing at a CAGR of 8.4% during the forecast period from 2023 to 2031. The demand for arteriotomy closure devices is surging due to the growing volume of cardiovascular and endovascular procedures globally. These devices are critical in achieving hemostasis post-catheterization, minimizing complications, improving patient outcomes, and reducing time to ambulation. Increased prevalence of cardiovascular diseases, rising healthcare expenditure, and the shift towards minimally invasive procedures are fueling market expansion.

Drivers:

1. Rising Prevalence of Cardiovascular Diseases:

With the global burden of heart-related conditions steadily increasing, the demand for effective and efficient closure of arterial puncture sites has intensified. This trend is boosting the uptake of arteriotomy closure devices across both developed and developing markets.

2. Shift Towards Minimally Invasive Procedures:

The medical field is experiencing a strong transition toward minimally invasive interventions, including percutaneous coronary intervention (PCI) and transcatheter aortic valve replacement (TAVR). These procedures require reliable and rapid arterial closure, favoring the adoption of closure devices.

3. Technological Advancements in Closure Devices:

Continuous innovations, such as the development of bioabsorbable materials and next-generation suture- and clip-based closure systems, are enhancing the safety, efficacy, and user-friendliness of arteriotomy closure devices.

Restraints:

1. Risk of Complications and Device Failures:

Though highly effective, some closure devices may pose risks such as infection, arterial stenosis, or embolism. Concerns over post-procedure complications and device-related failures limit market growth in risk-averse medical settings.

2. High Cost of Advanced Closure Systems:

Advanced closure devices, especially those using cutting-edge materials or mechanisms, are costlier than traditional compression techniques, making them less accessible in cost-sensitive healthcare markets.

Opportunity:

1. Growing Adoption in Ambulatory Surgical Centers:

The rise of outpatient-based vascular procedures has created substantial demand for rapid closure solutions to reduce discharge times, creating significant growth opportunities for arteriotomy closure devices.

2. Untapped Potential in Emerging Markets:

Emerging economies in Asia-Pacific and Latin America are witnessing improvements in healthcare infrastructure and procedural volumes, offering a fertile ground for market expansion through strategic partnerships and product localization.

Market by System Type Insights:

Based on system type, the Suture-Based Closure Devices segment led the market in 2023. These systems are widely used due to their precision and compatibility with large-bore procedures. Meanwhile, Clip-Based Closure Devices are expected to witness robust growth driven by their simplified deployment and immediate hemostasis capabilities, particularly in emergency settings.

Market by End-use Insights:

In terms of end use, Hospitals dominated the market in 2023, accounting for the largest share. The preference for hospital-based interventions, particularly in critical care and complex cardiovascular cases, supports this trend. Ambulatory Surgical Centers (ASCs) are expected to grow significantly due to the increasing number of same-day vascular interventions and the need for fast, effective closure solutions.

Market by Regional Insights:

North America held the largest share of the global arteriotomy closure devices market in 2023, driven by high procedural volumes, favorable reimbursement policies, and early adoption of innovative technologies. Europe follows closely, supported by established healthcare systems. However, the Asia-Pacific region is poised for the highest CAGR during the forecast period, fueled by expanding healthcare infrastructure and rising incidence of cardiovascular diseases in densely populated countries like India and China.

Competitive Scenario:

Prominent players in the Global Arteriotomy Closure Devices Market include Abbott Laboratories, Terumo Corporation, Cardinal Health, Teleflex Incorporated, Medtronic plc, and Morris Innovative, Inc. These companies are actively investing in R&D, mergers, and product portfolio expansion. For instance:

In 2024, Abbott launched a next-generation suture-mediated closure device aimed at improving patient recovery times post-PCI.

In 2023, Terumo received regulatory approval for its bioabsorbable closure device in multiple Asian markets, supporting its regional growth strategy.

In 2022, Teleflex expanded its portfolio with a patented collagen-based closure technology tailored for high-risk vascular patients.

Scope of Work – Global Arteriotomy Closure Devices Market

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.3 billion

CAGR (2023–2031) 8.4%

Market Segments By System Type (Suture-Based, Clip-Based, Collagen-Based), By End-use (Hospitals, Ambulatory Surgical Centers, Others)

Growth Drivers Rising cardiovascular procedures, Minimally invasive trends, Technological innovations

Opportunities Growth in ASCs, Emerging market expansion

Key Market Developments:

2024: Abbott launched its ProGlide Ultra device, offering enhanced suture deployment with fewer complications.

2023: Terumo Corporation secured CE mark approval for its bioabsorbable vascular closure device, broadening its European footprint.

2022: Teleflex acquired a vascular access start-up to accelerate innovation in closure technologies.

FAQs:

1) What is the current market size of the Global Arteriotomy Closure Devices Market?

The market was valued at USD 1.2 billion in 2023.

2) What is the major growth driver of the Global Arteriotomy Closure Devices Market?

The primary growth driver is the increasing number of cardiovascular procedures requiring effective arterial closure.

3) Which is the largest region during the forecast period in the Global Arteriotomy Closure Devices Market?

North America is the largest region, attributed to its advanced healthcare infrastructure and procedural volume.

4) Which segment accounted for the largest market share in the Global Arteriotomy Closure Devices Market?

The Suture-Based Closure Devices segment held the largest market share in 2023.

5) Who are the key market players in the Global Arteriotomy Closure Devices Market?

Key players include Abbott Laboratories, Terumo Corporation, Teleflex Incorporated, Cardinal Health, and Medtronic plc.